Elsevier BusinessIntelligence - With its third generation LVAD, MiTiHeart hopes it has the proper combination of a simple, robust and manufacturable design, low power consumption, and low rates of hemolysis, to serve a large, unmet need in congestive heart failure patients needing a permanent implant.
Bloomberg Businessweek - MiTiHeart Corporation develops and markets blood pumps for patients suffering from congestive heart failure. It offers MiTiHeart left ventricular assist device (LVAD, a centrifugal pump that exhibits low power loss, low vibration, low hemolysis, and high reliability under various conditions and varying pump orientations. The company was founded in 2003 and is based in Gaithersburg, Maryland. MiTiHeart Corporation operates as a subsidiary of Mohawk Innovative Technology, Inc.
One Med Place - In order to capitalize on the great market potential of the MiTiHeart blood pump, MiTi made a strategic decision to spin off the blood pump technology and establish the MiTiHeart Corporation as a wholly owned subsidiary of Mohawk Innovative Technology, Inc.
Copyright 2012 © - MiTiHeart Corporation - All Rights Reserved